RELAXO2021-10-012021-12-31in-bse-fin:OneOperatingExpenses01Member RELAXO2021-10-012021-12-31in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares RELAXO 2021-04-01 2022-03-31 2022-01-20 INR Crores Third quarter Single segment Footwear and Related Products 2021-10-01 2021-12-31 Unaudited Standalone 7435200000.00 54700000.00 7489900000.00 3412500000.00 241100000.00 -173700000.00 847400000.00 40600000.00 290700000.00 1891600000.00 6550200000.00 939700000.00 0.00 939700000.00 242400000.00 -3700000.00 238700000.00 0.00 701000000.00 0.00 0.00 0.00 0.00 701000000.00 -4300000.00 696700000.00 0.00 0.00 248900000.00 1 2.82 2.82 0.00 0.00 2.82 2.82 1. The above results were reviewed by the Audit Committee and have been approved by the Board of Directors at their meeting held on January 29, 2022. The Statutory auditors have conducted a limited review of the above unaudited financial results and have expressed an unmodified report on the same. 2.Based on guiding principles given in Ind AS 108 Operating Segments , the Company's business activity falls within a single operating segment namely, Footwear and Related Products , hence, the disclosure requirements relating to Operating Segments as per Ind AS 108 are not applicable. 3. During the quarter, 4,83,945 Equity Shares of face value of Re. 1/- each were allotted to the employees under Employee Stock Option Plan 2014. 4. During the quarter, additional capacity of 1.5 Lacs pair per day of footwear  has been commissioned  at unit located in Bhiwadi Rajasthan , taking the total capacity across all categories and Plants to 10 Lacs pair per day of footwear. 5. The Company has applied practical expedient as per amendment to Ind AS 116 “Leases” on COVID-19 related rent concessions and recognised gain of INR 0.62 crore and INR 5.61 crores respectively in other income for the quarter and nine months ended December 31, 2021 (INR 1.72 crores and INR 8.71 crores respectively for the quarter and nine months ended December 31, 2020). 6. The Company has done assessment of recoverability and carrying values of its assets comprising of receivables, inventories, plant and equipment, intangible assets and on the basis of assessment, the Company expects to recover the carrying amount of these assets. The Company will continue to closely monitor any material changes to future economic conditions due to uncertainties linked to COVID -19. Single segment 2021-04-01 2021-12-31 Unaudited Standalone 19550800000.00 178100000.00 19728900000.00 9560300000.00 653900000.00 -1242200000.00 2447800000.00 114300000.00 848400000.00 5084800000.00 17467300000.00 2261600000.00 0.00 2261600000.00 609800000.00 -45700000.00 564100000.00 0.00 1697500000.00 0.00 0.00 0.00 0.00 1697500000.00 -2800000.00 1694700000.00 0.00 0.00 248900000.00 1 6.83 6.82 0.00 0.00 6.83 6.82 Other Expenses 1891600000.00 Other Expenses 5084800000.00